Latest updates and new developments (45 minutes)
Attendee questions answered by the experts (15 minutes)
Andrew Alexis, MD, MPH
Professor and Chair
Department of Dermatology
Mount Sinai West and Mount Sinai Morningside
Director, Skin of Color Center
New York, New York
The goal of this initiative is to provide dermatologists and allergists with data on current and emerging therapies for moderate to severe AD that would have been presented at AAAAI 2020, RAD 2020 and AAD 2020.
The primary target audience for the activities includes dermatologists, immunologists, nurses, and other healthcare providers who treat patients with moderate to severe AD.
At the conclusion of this activity, learners should be able to:
- Critically evaluate study results from recent trials of AD regarding treatment efficacy and safety
- Describe how new trial data will affect/change the management of patients with AD
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.